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The vascular–stromal compartment of lymph nodes is important for lymph node func-
tion, and high endothelial venules (HEVs) play a critical role in controlling the entry of
recirculating lymphocytes. In autoimmune and autoinﬂammatory diseases, lymph node
swelling is often accompanied by apparent HEV expansion and, potentially, targeting HEV
expansion could be used therapeutically to limit autoimmunity. In previous studies using
mostly ﬂow cytometry analysis, we deﬁned three differentially regulated phases of lymph
node vascular–stromal growth: initiation, expansion, and the re-establishment of vascu-
lar quiescence and stabilization. In this study, we use optical projection tomography to
better understand the morphologic aspects of HEV growth upon immunization with oval-
bumin/CFA (OVA/CFA). We ﬁnd HEV elongation as well as modest arborization during the
initiation phase, increased arborization during the expansion phase, and, ﬁnally, vessel
narrowing during the re-establishment of vascular quiescence and stabilization. We also
examine acutely enlarged autoinﬂammatory lymph nodes induced by regulatory T cell
depletion and show that HEVs are expanded and morphologically similar to the expanded
HEVs in OVA/CFA-stimulated lymph nodes.These results reinforce the idea of differentially
regulated, distinct phases of vascular–stromal growth after immunization and suggest that
insights gained from studying immunization-induced lymph node vascular growthmay help
to understand how the lymph node vascular–stromal compartment could be therapeutically
targeted in autoimmune and autoinﬂammatory diseases.
Keywords: lymph node, high endothelial venules, stromal, angiogenesis, optical projection tomography, auto-
immunity, autoinflammation, regulatoryT cells
INTRODUCTION
Lymph nodes are sites of immune responses, and the lymph node
blood vessels are an integral part of immune function. In addi-
tion to the delivery of oxygen andmicronutrients, the lymph node
blood vessels deliver lymphocytes and other immune cells to the
lymph node parenchyma, where these cells can interact with anti-
gen and one another to generate an adaptive immune response.
Recirculating lymphocytes enter the lymph node parenchyma at
specialized postcapillary venules characterized by cuboidal, rather
than ﬂat, endothelial cells that are known as high endothelial
venules (HEVs). The HEV endothelial cells display chemokines
and adhesion molecules that promote the extravasation of lym-
phocytes. Peripheral lymph node HEVs are identiﬁed in part by
their expression of peripheral node addressin (PNAd)which binds
L-selectin on recirculating lymphocytes and thus allowing lym-
phocyte entry (von Andrian and Mempel, 2003; Benahmed et al.,
2012). The HEVs and the vessels in general are suspended within a
conduit network consisting of collagen-rich ﬁbrils ensheathed by
ﬁbroblastic reticular cells (FRCs). The conduit network is func-
tionally connected to the blood vessels, with FRCs or related
pericyte-like cells ensheathing the vessel walls (Gretz et al., 1997;
Malhotra et al., 2012). Disrupting trafﬁcking acrossHEVs disrupts
lymphocyte accumulation in lymph nodes and delays immune
responses (Arbones et al., 1994; Steeber et al., 1996; Xu et al., 1996).
Thus, insight into the events and regulation of HEV alterations
during immune responses may lead to new ways by which to
therapeutically manipulate immunity.
Lymph node enlargement induced by immunization or infec-
tion is associated with vascular expansion (Burwell, 1962; Herman
et al., 1972;Anderson et al., 1975;Mebius et al., 1990;Webster et al.,
2006; Kumar et al., 2010). Studies in recent years have begun to
delineate the mechanisms that regulate the growth of HEV and
other portions of the vasculature (Soderberg et al., 2005; Angeli
et al., 2006; Liao and Ruddle, 2006; Webster et al., 2006; Kumar
et al., 2010; Kataru et al., 2011). From our studies of lymph node
vascular growth after immunization, we have identiﬁed at least
three phases based on the vascular characteristics and regulatory
mechanisms. During the initiation phase from day 0 to day 2,
there is rapid upregulationof endothelial cell proliferationwhich is
independent of T andB cells, amodest increase inHEVendothelial
www.frontiersin.org September 2012 | Volume 3 | Article 282 | 1
“ﬁmmu-03-00282” — 2012/9/5 — 20:51 — page 2 — #2
Kumar et al. Immunization- and autoinﬂammatory-associated HEV alterations
cell numbers, but no expansion of non-HEV blood endothelial
cells. The initiation phase appears to involve at least a tripartite
interaction whereby dendritic or other CD11c+ cells stimulate
FRCs to upregulate VEGF, which then promotes endothelial cell
proliferation. The initiation phase is followed by an expansion
phase fromday 2 to about day 7 after ovalbumin/CFA (OVA/CFA),
and it is characterized by continued upregulated proliferation,
expansion of HEV, non-HEV blood, and lymphatic endothelial
cell numbers, expansion of FRC numbers, and dependence of
the proliferation and expansion on T and B cells (Webster et al.,
2006; Tzeng et al., 2010; Chyou et al., 2011; Benahmed et al., 2012).
After expansion, the vessels become more quiescent, with reduced
endothelial cell proliferation and HEV trafﬁcking efﬁciency. Stim-
ulating the lymph node transiently with bone marrow-derived
dendritic cells leads to cessation of vascular expansion at this
stage, but a chronic stimulus such as with OVA/CFA leads to
continued expansion as the proliferation rate slowly drops. Re-
establishment of vessel stabilization accompanies the quiescence,
with FRCs more tightly organized around HEVs. The quiescence
and stabilization are mediated by CD11chi presumed dendritic
cells, as depletion of CD11chi cells during this phase results in
increased endothelial cell proliferation, disorganization of the FRC
sheath around the vessels, and increased vascular permeability
(Tzeng et al., 2010).
In autoimmune and autoinﬂammatory disorders such as sys-
temic lupus erythematosus and systemic onset juvenile arthritis,
lymph nodes can be hypertrophic (Fox and Rosahn, 1943; Shapira
et al., 1996; Schneider and Laxer, 1998; Calguneri et al., 2003;
Livingston et al., 2011). Apparent blood vascular proliferation
is one of the characteristics of these enlarged lymph nodes
(Benahmed et al., 2012). We recently showed in a chronic lupus
model that the expanded lymph node vasculature is in a state
of re-established quiescence as seen by a low endothelial cell
proliferation rate, reduced HEV trafﬁcking efﬁciency, and the
accumulation of CD11chi cells (Chyou et al., 2012). Among other
things, these results suggested that insights gained from study-
ing lymph nodes stimulated by model immunization strategies
may be applicable to vascular regulation in chronic autoim-
mune models and, potentially, in human disease. While the
lymph nodes in the chronic lupus model steadily enlarged over
weeks (Chyou et al., 2012), lymph nodes in human lupus and
systemic onset juvenile arthritis can also acutely enlarge (Fox
and Rosahn, 1943; Eisner et al., 1996; Grom and Passo, 1996).
Whether acute lymphadenopathy associated with autoimmu-
nity or autoinﬂammation can be accompanied by an expanded
vasculature and whether this expansion shares features with
acute vascular expansion induced by OVA/CFA immunization is
unknown.
Blood vessel expansion in immune-stimulated lymph nodes
was demonstrated decades ago using techniques such as resin cast-
ing and microangiography (Burwell, 1962; Herman et al., 1972;
Anderson et al., 1975; Steeber et al., 1987). Optical projection
tomography (OPT) is an imaging technique developed 10 years
ago whereby the specimen is rotated while a ﬁxed detector obtains
light or ﬂuorescent images through the course of the 360◦ rota-
tion, allowing a three-dimensional rendering of the specimen. The
apparatus for OPT data capture displays many similarities to a
micro-computer tomography (CT) scanner: a stepper motor is
used to rotate the specimen to precisely controlled angles, a 2D
array detector (CCD) is used to capture the signal, and photon
sources are included for illumination. OPT generally employs rel-
atively low numerical aperture optics, which provide the large
depth of ﬁeld and working distance needed to analyze thick sam-
ples. The use of visible light and image-forming optics is one of
the important advantages of OPT – it is capable of being used in
two different modalities: transmission OPT (tOPT), and emission
OPT (eOPT). The use of optics in OPT allows a sharp image to be
focusedonto theCCD,yielding images that canbe considered good
approximations to projections for computational purposes. OPT
is ideal for specimens 1–10 mm in size (Sharpe et al., 2002) and
has been used in studies of organ development during embryo-
genesis (Davies and Armstrong, 2006). Recently, OPT was used
to study HEV growth associated with virus-induced lymph node
hypertrophy (Kumar et al., 2010).
In this current study, we use OPT to characterize the morpho-
logic aspects of HEV growth upon immunization with OVA/CFA
and compare that with the HEV alterations that occur in an acute
autoimmune and autoinﬂammatory model induced by depletion
of regulatory T cells. The results show (1) distinct morpho-
logic alterations during the different phases of vascular growth
after immunization, (2) that HEVs in acutely enlarged autoin-
ﬂammatory lymph nodes are expanded, and (3) that there are
morphologic similarities between expandedHEVs in the twomod-
els. These results reinforce the idea of distinct phases of lymph
node vascular growth after immunization and raise the possibil-
ity that insights gained from studying lymph nodes stimulated
by OVA/CFA and other experimental immunization strategies
may be useful in understanding and treating autoimmune and
autoinﬂammatory diseases.
MATERIALS AND METHODS
MICE
C57Bl/6 mice between 6 and 12 weeks of age were obtained from
Jackson Laboratory (Bar Harbor,ME,USA), Taconic Farms (Hud-
son,NY,USA) or National Cancer Institute (Frederick,MD,USA).
Foxp3-DTR mice were originally generated as described (Kim
et al., 2007). All procedures were performed in accordance with
the Institutional Animal Use and Care Committee of the Hospital
for Special Surgery.
MOUSE TREATMENTS AND IMMUNIZATIONS
For immunization with OVA in complete Freund’s adjuvant
(OVA/CFA), OVA was emulsiﬁed in CFA at ﬁnal concentration
of 1 mg/ml OVA, and mice received hind footpad injection of
20 μl of OVA/CFA as described (Webster et al., 2006).
Foxp3-DTR mice express simian diphtheria toxin (DT) recep-
tor that allows for depletion of Foxp3+ regulatory T cells upon
DT administration (Kim et al., 2007; Chinen et al., 2010). For reg-
ulatory T cell depletion, wild-type control or Foxp3-DTR mice
were injected intraperitoneally with 1.5 μg of DT (Calbiochem,
San Diego, CA, USA or List Biological Laboratory, Campbell, CA,
USA) on days 0, 1, 4, and 7 and examined on day 8. CD4+, CD25+,
Foxp3+ regulatory T cells in lymph nodes were depleted by at least
12-fold by day 8.
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FLOW CYTOMETRY ANALYSIS
For ﬂow cytometric analysis of endothelial cells and FRCs, we
generated single cell suspensions from lymph nodes and stained
cells as previously described (Webster et al., 2006). Brieﬂy, lymph
nodes were digested with collagenase type II (Worthington,
Lakewood, NJ, USA) and stained with antibodies for ﬂow cytom-
etry. Antibodies to the following antigens were used: CD45
(BD Biosciences, San Jose, CA, USA), CD31 (BD Biosciences),
PNAd (clone MECA-79, BD Biosciences), gp38 (Biolegend, San
Diego, CA, USA or Developmental Studies Hybridoma Bank,
Iowa City, IA, USA). The unconjugated anti-PNAd is detected
using ﬂuorophore-conjugated anti-rat IgM (Jackson ImmunoRe-
search, West Grove, PA, USA). Cells were analyzed using a FACS
CANTOS (BD Biosciences) and CellQuest Pro (BD Biosciences)
software.
OPTICAL PROJECTION TOMOGRAPHY
MECA-79 conjugation was performed according to vendor
instructions using Alexa-568 conjugation kit (Invitrogen, Carls-
bad, CA, USA) and visualization of the HEVs by OPT (eOPT
modality) was performed essentially as described in Kumar et al.
(2010). To label the HEVs, 15μg of Alexa-568-conjugatedMECA-
79 was injected intravenously into the mouse at 20 min prior to
lymph node excision. Excised lymph nodes were cleaned of fat,
ﬁxed in 1% ultrapure paraformaldehyde (Electron Microscopy
Sciences, Hatﬁeld, PA, USA) for 4 h at 4◦C and then washed in
PBS. The lymph nodes were embedded in 1% ultrapure agarose
(Invitrogen) and then dehydrated in 100% methanol overnight.
The lymph nodes were then immersed in BABB solution (benzyl
alcohol+ benzyl benzoate at 1:2 ratio) andOPT scanningwas per-
formed according to themanufacturer’s instructions (Bioptonics).
Filter sets were: exciter 425/40, emitter LP475 for autoﬂuores-
cent signal and exciter 545/30, emitter 617/75 for red ﬂuorescent
signal. Raw data were converted into 3D voxel datasets using NRe-
con software from Bioptonics. Reconstructed virtual xyz data sets
were exported as .TIFF or .bmp ﬁles and analyzed with IMARIS
(Bitplane) for isosurface calculation of total lymph node volume.
IMARIS reconstructions were carefully adjusted to ﬁt original
NRecon reconstructions. The total HEV length and thickness,
branching points, and individual/average segment lengths were
obtained by using the IMARIS Filament tracer module (Bitplane).
Segments were deﬁned as an HEV section between 2 branching
points.
RESULTS
OPT CHARACTERIZATION OF HEV GROWTH AFTER
IMMUNIZATION WITH OVA/CFA
WeusedOPT to examine themorphologic alterations that occur as
HEVs expand after immunization with OVA/CFA. TheHEVs were
labeled prior to imaging with intravenously injected ﬂuorophore-
tagged MECA-79, allowing us to visualize HEVs that express the
PNAd epitope recognized by MECA-79 on the luminal surface.
We examined the nodes at days 2, 4, 7, 14, and 21 to examine the
morphologic alterations that occur during initiation, expansion,
and the re-establishment of quiescence and stabilization. Popliteal
lymph node volume was increased by day 2 after footpad immu-
nization with OVA/CFA (Figures 1A,B), consistent with the rapid
increase in lymph node cellularity observed previously (Webster
et al., 2006; Tzeng et al., 2010; Chyou et al., 2011). TotalHEV length
doubled (Figure 1C). There was a modest increase in segment
numbers as well as branch points (Figures 1D,E), suggesting that
some of the HEV growth was attributable to the generation of
new branches. The average segment length also increased, with
the proportion of the longer segments increasing and segments
over 200 μm doubling (Figures 1F,H). This suggested that HEV
elongation contributed to HEV growth at day 2. HEV width was
reduced at day 2 (Figures 1G,I), suggesting vasoconstriction or
vessel stretching.
Lymph node volume and total HEV length increased further
by day 4 (Figures 1B,C). Segment numbers and branch points
showed continued increases while segment length did not increase
from day 2 levels (Figures 1D–F,H). This suggested that the con-
tinuedHEV growth at day 4 wasmainly due to vessel arborization.
Vessel width was restored to day 0 levels, further supporting the
idea of HEV expansion (Figures 1G,I). At day 7, at a point when
endothelial cell numbers are still expanding afterOVA/CFA immu-
nization (Tzeng et al., 2010), the combination of high segment
numbers and branch points along with a reduction in segment
length relative to that of day 4 (Figures 1D–F,H) suggested con-
tinued arborization and limited segment elongation. After day 7,
when we have previously observed the re-establishment of vascu-
lar quiescence and stabilization (Tzeng et al., 2010), total HEV
length, segment numbers, branch points, and segment length
remained constant (Figures 1C–F,H) while vessel width decreased
(Figures 1G,I), suggesting cessation of HEV growth and the pro-
cess of vessel narrowing. Together, these results suggested that
there is an initial HEV elongation and modest arborization in the
ﬁrst 2 days that is followed by increased HEV arborization and,
after day 7, vessel narrowing.
THE HEVs IN ACUTE AUTOINFLAMMATORY LYMPHADENOPATHY
RESEMBLE HEVs AT DAYS 4–7 AFTER IMMUNIZATION WITH OVA/CFA
We asked whether we could observe apparent vascular expansion
in acutely enlarged lymph nodes associated with an autoim-
mune and autoinﬂammatory model and whether the expanded
vasculature shared features with that induced byOVA/CFA immu-
nization. Depletionof regulatoryT cells in Foxp3-DTRmice byDT
injection results in an acute autoimmune and inﬂammatory phe-
notype characterized by rampant inﬂammation, T cell activation,
splenomegaly, lymphadenopathy, and autoantibody production
by day 8 anddeath starting at day 10 (Kim et al., 2007; Chinen et al.,
2010). As it is unknown whether the peripheral lymphadenopa-
thy is directly driven by antigen-speciﬁc autoimmune responses
or by the generalized autoinﬂammation, we will refer to the lym-
phadenopathy here as “autoinﬂammatory” in origin. We treated
(control)wild-typemice andFoxp3-DTRmicewithDTand exam-
ined lymph nodes at day 8. OPT analyses showed that lymph node
volume, totalHEV length, number of segments, number of branch
points, and segment lengthwere all increased inDT-treatedFoxp3-
DTR mice relative to wild-type mice (Figures 2A–F,H). Vessel
width was similar in theWT and Foxp3-DTRmice (Figures 2G,I).
The magnitude of the alterations in the Foxp3-DTR mice was
similar to that at days 4–7 after OVA/CFA immunization (com-
pare Figures 1A–I with Figures 2A–I). These results suggested
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FIGURE 1 | Initial HEV lengthening is followed by branching and then
narrowing after OVA/CFA. Mice were immunized in the footpad with
OVA/CFA on day 0 and draining popliteal nodes were prepared for OPT
imaging of PNAd+ vessels on indicated days. (A) Representative images
from OPT scanning. (B)Total lymph node volume. (C)Total length of HEV per
lymph node. (D) Number of HEV segments per lymph node. (E) Number of
branch points per lymph node. (F) Average segment length. (G) Average
vessel width. (H) Relative distribution of segment lengths. Lengths were
divided into discrete “bins” and the percent of segments in each bin was
calculated and graphed. (I) Relative distribution of segment width.Widths
were divided into discrete “bins” and the percent of segments in each bin
was calculated and graphed. For (B–G), *p < 0.05 and **p < 0.01 relative to
day 0 measurement using t -test. Error bars represent standard deviations.
n = 3–5 lymph nodes for each condition.
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FIGURE 2 | High endothelial venule (HEV) growth in Foxp3-DTR mice is
similar to that induced by OVA/CFA immunization.Wild-type (WT) and
Foxp3-DTR (DTR) mice were injected with DT to deplete regulatory T cells as
per Section “Materials and Methods” and popliteal lymph nodes were
prepared for OPT imaging of PNAd+ vessels. (A) Representative image of
Foxp3-DTR lymph node fromOPT scanning. Scale is same as that of Figure 1A
to allow comparisons to nodes stimulated with OVA/CFA. (B)Total lymph
node volume. (C)Total length of HEV per lymph node. (D) Number of HEV
segments per lymph node. (E) Number of branch points per lymph node. (F)
Average segment length. (G) Average vessel width. (H) Relative distribution of
segment lengths. Lengths were divided into discrete “bins” and the percent
of segments in each bin was calculated and graphed. (I) Relative distribution
of segment width.Widths were divided into discrete “bins” and the percent
of segments in each bin was calculated and graphed. For (B–G), *p < 0.05
and **p < 0.01 relative toWT mice measurement using t -test. Error bars
represent standard deviations. n = 4 lymph nodes for each condition.
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that the HEVs in the acutely enlarged autoinﬂammatory lymph
nodes were expanded and shared morphologic features with the
expandedHEVs of lymphnodes acutely stimulatedwithOVA/CFA
immunization.
To further characterize vascular–stromal alterations in addition
to HEV morphologic characteristics in the regulatory T cell-
depleted mice, we enumerated endothelial cells and FRCs in the
brachial nodes of the DT-treated Foxp3-DTRmice by ﬂow cytom-
etry. Lymph node cellularity was increased by four- to ﬁvefold in
the Foxp3-DTR brachial nodes (Figure 3A), a number fairly con-
sistent with the six- to sevenfold increase in volume seen by OPT
in the popliteal nodes (Figure 2B). As we have done previously, we
gated as shown in Figure 3B to derive counts for endothelial cell
subpopulations. CD45−CD31+ cells are “total endothelial cells”
that can be subsetted into PNAd+ “HEV endothelial cells” and
PNAd− “non-HEV mixed” lymphatic and blood endothelial cells.
The non-HEV mixed endothelial cells can be further subsetted
into gp38+ “lymphatic endothelial cells” and gp38− “non-HEV
blood endothelial cells.” The three- to fourfold increase in HEV
endothelial cell numbers in the Foxp3-DTR mice (Figure 3C)
was consistent with the four- to ﬁvefold increase in total HEV
length observed in popliteal nodes using OPT (Figure 2C). In
contrast to the HEV endothelial cells, the number of non-HEV
blood endothelial cells was not increased in the Foxp3-DTR
mice (p = 0.68, t-test, n = 3 per condition; Figure 3C). Lym-
phatic endothelial cells and (CD45−CD31−gp38+) FRCs showed
a suggestion toward increased numbers in the Foxp3-DTR mice
(Figure 3C,D), but the differences did not reach statistical signiﬁ-
cance (p = 0.12 for lymphatic endothelial cells; p = 0.14 for FRCs).
These ﬂow cytometry results corroborated the OPT results show-
ing HEV expansion in the autoinﬂammatory lymph nodes and
indicated that, at the time point examined, HEVs but not other
FIGURE 3 | Diphtheria toxin-treated Foxp3-DTR mice also shows
more generalized lymph node vascular–stromal growth.Wild-type
(WT) and Foxp3-DTR (DTR) mice were injected with DT as per Section
“Materials and Methods” and brachial lymph nodes were analyzed by
ﬂow cytometry. (A) Lymph node cellularity. (B) Flow cytometry plots to
demonstrate gating of endothelial cell subpopulations. (C) Enumeration
of endothelial cell subpopulations. (D) Enumeration of gp38+ FRCs per
lymph node. For (A,C,D), *p < 0.05, t -test, n = 3 mice per condition.
For (C), t -test is relative to the same endothelial cell subset in
WT mice.
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subpopulations of the vascular–stromal compartment examined
were expanded.
DISCUSSION
In this study, we characterized the morphologic features of HEV
expansion after OVA/CFA immunization and examined the HEVs
in a model of acute autoinﬂammatory lymphadenopathy. We
used OPT, which detects changes in HEVs expressing luminal
PNAd. Because PNAd can be expressed both luminally and ablu-
minally and it is possible for someHEVs to express only abluminal
PNAd (Hemmerich et al., 2001; Drayton et al., 2003; Liao and
Ruddle, 2006), OPT may miss remodeling involving cells express-
ing only abluminal PNAd. Nevertheless, the results reinforce the
concept that there are distinct phases of lymph node vascular
growth induced after immunization and demonstrate that acute
autoinﬂammatory lymphadenopathy can be associated with HEV
expansion. The HEV expansion with autoinﬂammation and mor-
phologic similarities with HEVs in OVA/CFA-stimulated lymph
nodes raise the possibility that insights gained from studying
lymph nodes responding to exogenous stimuli may help to bet-
ter understand vascular–stromal regulation in autoimmune and
autoinﬂammatory diseases.
The initial elongation of HEV after OVA/CFA immunization
followed by dominance of arborization corresponds with the ﬁnd-
ings of Anderson et al. (1975) who used intra-arterial Alcian blue
dye and thick sections to study the lymph node vasculature. The
initial segment elongation at day 2 could be due to either ves-
sel stretching, as vessel width was reduced at this time point,
or to the addition of PNAd+ endothelial cells to existing seg-
ments. In support of the latter, ﬂow cytometric analysis showed
a doubling of PNAd+ endothelial cell numbers at day 2 (Chyou
et al., 2011). However, as ﬂow cytometry is likely able to detect
cells expressing only abluminal PNAd as well as cells expressing
luminal PNAd, we cannot rule out that the additional PNAd+
cells detected by ﬂow cytometry are cells expressing only ablumi-
nal PNAd and that elongation seen by OPT may simply reﬂect
stretching. The subsequent increased arborization and expansion
seen at days 4–7 corresponds well in time to the large increase in
PNAd+ endothelial cell numbers that is seen during the expan-
sion phase (Chyou et al., 2011). With OVA/CFA, endothelial cell
numbers plateau at day 8 (Tzeng et al., 2010), similar to the
plateau of HEV expansion seen with OPT at day 7. Given that
the expansion of endothelial cell numbers is dependent primar-
ily on B cells (Chyou et al., 2011), the dependence of branching
expansion on B cells seen in the viral infection-induced model
(Kumar et al., 2010) ﬁts well with the idea that the increased
arborization is the morphologic correlate of the increase in
endothelial cell numbers seen during the lymphocyte-dependent
vascular–stromal expansion phase. During the re-establishment
of quiescence and stabilization after expansion, vessels become
less leaky and FRCs reorganize more tightly around the ves-
sels (Tzeng et al., 2010). The narrowing of vessels observed after
day 7, then, may be the morphologic correlate of vascular
stabilization. We have identiﬁed a role for CD11chi presumed
dendritic cells in mediating the reduced permeability and reor-
ganization of FRCs (Tzeng et al., 2010), and it will be of interest
in future studies to understand whether the HEV narrowing is
also dependent on CD11chi cells. Therefore, new data presented
here add to our model of multiple phases of vascular expan-
sion following peripheral immunization. Taking these data along
with our previous studies, we propose that vascular expansion
is comprised of (1) a CD11c+ cell-dependent, lymphocyte-
independent initiation phase that is characterized by upregulation
of vascular–stromal proliferation and a modest increase in HEV
endothelial cell numbers resulting in HEV elongation and mod-
estly increased arborization, (2) a lymphocyte-dependent phase
characterized by continued vascular–stromal proliferation, gen-
eralized vascular–stromal expansion, and HEV growth that is
mainly due to arborization, and (3) a CD11chi cell-dependent
re-establishment of quiescence and stabilization that involves the
re-accumulation of FRCs around vessels and consequent vessel
narrowing.
Similar to the enlarged lymph nodes induced by immuniza-
tion with OVA/CFA, enlarged lymph nodes in the DT-treated
Foxp3-DTR mice also showed HEV expansion, lengthening, and
branching. The magnitude of these changes at day 8 after the ﬁrst
injection of DT is similar to the changes at days 4–7 afterOVA/CFA
and this slight delay may be attributable to time required for reg-
ulatory T cell depletion. Consistent with the idea that these lymph
nodes at day 8 are similar to a relatively early time point after
exogenous immunization is the lack of non-HEV blood endothe-
lial cell expansion, as HEV endothelial cells expand more rapidly
than non-HEV blood endothelial cells after immunization with
OVA/CFA or bone marrow-derived dendritic cells (Tzeng et al.,
2010; Chyou et al., 2011). The death of animals by day 10 after
regulatory T cell depletion (Kim et al., 2007) precludes satisfactory
longer term analysis of the vascular–stromal growth to understand
whether non-HEV endothelial cells and the rest of the vascular–
stromal compartment also later expand, but it will be of interest to
further examine the early events of HEV growth in the Foxp3-DTR
mice to understandwhether initial stages of HEVexpansion is sim-
ilar to that induced by OVA/CFA. Interestingly, HEV expansion at
days 4–7 in the OVA/CFA model is similar to that at day 8 after
LCMV infection in terms of total HEV length and segment num-
bers (Kumar et al., 2010), and the two models share a dependence
on B cells (Kumar et al., 2010; Chyou et al., 2011) and multiple
models share sensitivity to lymphotoxin beta receptor blockade
(Liao and Ruddle, 2006; Kumar et al., 2010; Benahmed and Lu,
unpublished observations) for induced HEV expansion. How-
ever, in the LCMV model, HEV branching precedes elongation
(Kumar et al., 2010), suggesting stimulus-dependent differences
in the initiation of HEV growth. The morphologic similarities
of the expanded HEVs in the Foxp3-DTR mice with that after
acute OVA/CFA immunization or viral infection (Kumar et al.,
2010) suggests the possibility of at least some shared regulatory
mechanisms.
We used regulatory T cell depletion as a means to induce a
model of autoimmunity and autoinﬂammation, but it is possi-
ble that the associated lymph node vascular expansion reﬂects
direct regulatory T cell activity on the vascular–stromal compart-
ment. This would be consistent with studies that have implicated
regulatory T cells in directly limiting endothelial cell activation
(He et al., 2010; Matrougui et al., 2011). However, we have shown
that CD11c+ cells are important for the initiation of lymph node
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vascular growth (Webster et al., 2006; Tzeng et al., 2010; Chyou
et al., 2011). Regulatory T cell depletion results in the accu-
mulation and activation of dendritic and other CD11c+ cells
(Kim et al., 2007; Lund et al., 2008), raising the possibility that
regulatory T cell depletion resulted in lymph node vascular expan-
sion at least in part by promoting CD11c+ cell activation and
accumulation.
Lymphadenopathy in diseases such as lupus and systemic
onset juvenile arthritis can occur acutely with disease ﬂare. Our
results here suggest that acutely enlarged lymph nodes in the set-
ting of an autoimmune and autoinﬂammatory model can have
an expanded HEV compartment and that these HEVs share
some similarities with those seen after immunization with exoge-
nous stimuli. These results suggest the possibility that insights
gleaned from vascular–stromal regulation in immunization mod-
els may be instructive for understanding how to therapeuti-
cally control immunity in autoimmune and autoinﬂammatory
diseases.
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